These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14607962)

  • 1. Direct inhibition of NF-kappa B blocks bone erosion associated with inflammatory arthritis.
    Clohisy JC; Roy BC; Biondo C; Frazier E; Willis D; Teitelbaum SL; Abu-Amer Y
    J Immunol; 2003 Nov; 171(10):5547-53. PubMed ID: 14607962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of inflammatory bone erosion by constitutively active STAT-6 through blockade of JNK and NF-kappaB activation.
    Hirayama T; Dai S; Abbas S; Yamanaka Y; Abu-Amer Y
    Arthritis Rheum; 2005 Sep; 52(9):2719-29. PubMed ID: 16142755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.
    Jimi E; Aoki K; Saito H; D'Acquisto F; May MJ; Nakamura I; Sudo T; Kojima T; Okamoto F; Fukushima H; Okabe K; Ohya K; Ghosh S
    Nat Med; 2004 Jun; 10(6):617-24. PubMed ID: 15156202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
    Lubberts E; van den Bersselaar L; Oppers-Walgreen B; Schwarzenberger P; Coenen-de Roo CJ; Kolls JK; Joosten LA; van den Berg WB
    J Immunol; 2003 Mar; 170(5):2655-62. PubMed ID: 12594294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.
    Juarranz Y; Abad C; Martinez C; Arranz A; Gutierrez-Cañas I; Rosignoli F; Gomariz RP; Leceta J
    Arthritis Res Ther; 2005; 7(5):R1034-45. PubMed ID: 16207319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel inhibitor of I-kappaB kinase beta ameliorates experimental arthritis through downregulation of proinflammatory cytokines in arthritic joints.
    Tanaka S; Toki T; Yokoyama M; Shimizu H; Yamasaki T; Yoneda Y; Muro F; Yasukochi T; Iimura S; Morishita K
    Biol Pharm Bull; 2014; 37(1):87-95. PubMed ID: 24389485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction.
    Mbalaviele G; Anderson G; Jones A; De Ciechi P; Settle S; Mnich S; Thiede M; Abu-Amer Y; Portanova J; Monahan J
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1044-53. PubMed ID: 16501068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis.
    Lee HY; Jeon HS; Song EK; Han MK; Park SI; Lee SI; Yun HJ; Kim JR; Kim JS; Lee YC; Kim SI; Kim HR; Choi JY; Kang I; Kim HY; Yoo WH
    Arthritis Rheum; 2006 Jun; 54(6):1747-58. PubMed ID: 16736517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model.
    Ren W; Wu B; Peng X; Mayton L; Yu D; Ren J; Chen BD; Wooley PH
    J Orthop Res; 2006 Feb; 24(2):280-90. PubMed ID: 16435361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with N-tosyl-l-phenylalanine chloromethyl ketone after the onset of collagen-induced arthritis reduces joint erosion and NF-kappaB activation.
    Choi J; Ha KH; Byun MS; Min SY; Park MJ; Park HS; Oh HJ; Ju JH; Kim HY; Jue DM
    Eur J Pharmacol; 2008 Oct; 595(1-3):108-13. PubMed ID: 18706406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-specificity phosphatase 1-null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis.
    Vattakuzhi Y; Abraham SM; Freidin A; Clark AR; Horwood NJ
    Arthritis Rheum; 2012 Jul; 64(7):2201-10. PubMed ID: 22275313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α2β1 integrin regulates Th17 cell activity and its neutralization decreases the severity of collagen-induced arthritis.
    El Azreq MA; Boisvert M; Cesaro A; Pagé N; Loubaki L; Allaeys I; Chakir J; Poubelle PE; Tessier PA; Aoudjit F
    J Immunol; 2013 Dec; 191(12):5941-50. PubMed ID: 24244022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
    Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P
    Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclasts are essential for TNF-alpha-mediated joint destruction.
    Redlich K; Hayer S; Ricci R; David JP; Tohidast-Akrad M; Kollias G; Steiner G; Smolen JS; Wagner EF; Schett G
    J Clin Invest; 2002 Nov; 110(10):1419-27. PubMed ID: 12438440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
    Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
    Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
    Khapli SM; Mangashetti LS; Yogesha SD; Wani MR
    J Immunol; 2003 Jul; 171(1):142-51. PubMed ID: 12816992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis.
    Okamoto H; Iwamoto T; Kotake S; Momohara S; Yamanaka H; Kamatani N
    Clin Exp Rheumatol; 2005; 23(3):323-30. PubMed ID: 15971419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human endostatin inhibits TNF-alpha-induced receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes in mice with adjuvant arthritis.
    Gao QF; Zhang XH; Yuan FL; Zhao MD; Li X
    Cell Biol Int; 2016 Dec; 40(12):1340-1348. PubMed ID: 27730697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.